sought
determin
whether
human
leukocyt
antigenb
hlab
locu
role
outcom
sebov
diseas
type
case
outbreak
northern
uganda
sequencebas
hlab
type
perform
use
leukocyt
isol
patient
statist
analysi
predict
discrimin
analysi
pda
appli
type
data
epitop
predict
softwar
also
appli
sebov
sequenc
statist
signific
associ
found
certain
set
allel
either
fatal
nonfat
diseas
outcom
allel
b
b
associ
fatal
outcom
wherea
b
b
associ
nonfat
outcom
pdaderiv
function
produc
accur
classifi
patient
correct
outcom
group
sever
epitop
predict
bind
strongli
hlab
molecul
identifi
viral
polymeras
nucleoprotein
protein
hlab
allel
associ
either
fatal
nonfat
outcom
sebov
diseas
identifi
use
predict
model
studi
hlabrestrict
epitop
could
contribut
character
protect
host
respons
vaccin
develop
human
andor
nonhuman
primat
ebola
viru
ebov
infect
caus
sever
form
hemorrhag
fever
lead
death
infect
control
human
infect
caus
zair
ebov
zebov
sudan
ebov
sebov
account
document
case
result
mortal
rate
roughli
respect
surviv
acut
infect
depend
abil
effici
clear
viru
infect
cell
bodi
viru
replic
becom
unrestrict
studi
ebov
infect
human
anim
model
indic
import
compon
immun
respons
cellmedi
immun
humor
immun
appear
play
minor
role
surviv
ebov
diseas
antibodi
respons
characterist
delay
ie
absent
earli
usual
undetect
fatal
case
passiv
transfer
antiserum
effect
protect
primat
antibodi
may
actual
enhanc
entri
ebov
host
cell
nk
cell
may
contribut
clearanc
evid
suggest
play
signific
role
control
ebov
infect
studi
infect
macaqu
indic
progress
deplet
cell
cours
diseas
earli
septemb
larg
outbreak
sebov
diseas
identifi
northern
region
uganda
center
around
citi
gulu
team
center
diseas
control
prevent
cdc
atlanta
particip
intern
effort
control
outbreak
sebov
diseas
provid
onsit
diagnost
test
blood
sampl
observ
progress
diseas
mani
patient
person
infect
sebov
show
sign
symptom
diseas
asymptomat
case
identifi
yet
patient
observ
diseas
milder
sever
shorter
durat
analysi
acutephas
peripher
blood
mononuclear
cell
pbmc
sebovinfect
patient
show
signific
differ
express
cytokin
fa
fa
ligand
patient
fatal
nonfat
case
compar
compar
uninfect
hospit
patient
howev
person
nonfat
outcom
differ
person
fatal
outcom
lower
viral
load
well
greater
number
cell
activ
hladr
cell
find
suggest
product
cytotox
lymphocyt
ctl
import
limit
sebov
replic
reduc
diseas
sever
cellmedi
immun
like
critic
compon
surviv
sebov
infect
postul
hla
class
composit
infect
patient
could
influenc
cours
diseas
investig
possibl
blood
specimen
collect
varieti
sebovinfect
patient
use
sequencebas
type
hlab
locu
exon
diverg
major
histocompat
complex
mhc
class
gene
fortun
larg
number
case
sampl
fatal
rate
associ
outbreak
allow
statist
analysi
perform
data
gener
result
investig
subject
present
articl
implic
certain
allel
either
nonfat
fatal
outcom
diseas
due
sebov
accord
cdc
institut
review
board
polici
sampl
anonym
identifi
fatal
nonfat
case
sequenc
inform
patient
infect
ebov
gener
reversetranscrib
mrna
cdna
produc
anoth
studi
brief
total
rna
isol
pbmc
cdna
produc
prime
oligod
random
hexam
extend
superscript
ii
revers
transcriptas
rna
remov
rnase
h
invitrogen
catalog
hlab
locu
sequencebas
type
human
hlab
sequenc
polymeras
chain
reaction
pcr
amplifi
cdna
use
platinum
pcr
supermix
invitrogen
expand
high
fidel
system
roch
appli
scienc
decreas
background
amplif
vv
dimethyl
sulfoxid
sigmaaldrich
includ
reaction
amplif
exon
accomplish
use
primer
end
exon
begin
exon
separ
amplif
exon
accomplish
use
primer
begin
exon
amplif
exon
primer
end
exon
amplicon
length
bp
respect
figur
thermocycl
condit
amplif
follow
round
denatur
anneal
extens
pcr
amplif
gener
requir
use
primer
produc
enough
templat
dna
direct
sequenc
howev
time
use
andor
primer
combin
need
increas
amplicon
synthesi
amplicon
separ
reaction
compon
electrophoresi
agaros
ethidium
bromidestain
band
isol
use
qiagen
qiex
ii
dna
elut
bind
matrix
use
nucleasefre
water
cycl
sequenc
amplicon
perform
use
prism
bigdy
chemistri
version
appli
biosystem
reaction
contain
ng
primer
separ
reaction
perform
use
primer
reaction
prepar
thinwal
pcr
tube
heat
min
follow
cycl
denatur
anneal
extens
min
extens
product
isol
pass
reaction
centrisep
column
princeton
separ
thoroughli
dri
speed
vacuum
product
analyz
autom
sequenc
abi
abi
prism
appli
biosystem
accord
manufactur
protocol
sequench
softwar
version
gene
code
use
analyz
chromatograph
file
gener
consensu
hlab
sequenc
export
ascii
file
hlab
allel
assign
gener
use
assign
softwar
program
version
sequencebas
type
develop
sayer
j
meier
depart
clinic
immunolog
royal
perth
hospit
perth
australia
descript
assign
version
publish
elsewher
recent
version
avail
conexio
genom
hlab
assign
limit
allel
type
ie
b
b
provid
sampl
size
larg
enough
perform
statist
analys
epitop
predict
encod
amino
acid
sequenc
gene
sudan
ebov
gulu
analyz
use
internetbas
softwaretool
identifi
epitop
potenti
involv
cellmedi
immun
respons
analys
use
ctlpred
direct
method
predict
ctl
epitop
well
follow
indirect
method
base
mhc
antigenbind
properti
bima
rankpep
epijen
netctl
arb
matrix
note
method
also
factor
proteasom
ctermin
cleavag
tap
bind
statist
data
analysi
predict
discrimin
analysi
pda
techniqu
use
predict
surviv
among
fisher
exact
test
use
initi
screen
devic
determin
hlab
allel
associ
patient
surviv
allel
consid
inclus
pda
model
univari
associ
patient
surviv
result
p
valu
initi
set
predictor
variabl
select
univari
analys
allposs
subset
approach
use
select
set
hlab
allel
maxim
classif
accuraci
accuraci
pda
model
assess
examin
overal
individu
group
hit
rate
hit
rate
estim
use
leaveoneout
loo
method
crossvalid
procedur
produc
classif
estim
nearli
unbias
estim
true
popul
hit
rate
overal
hitrat
estim
statist
compar
chanc
expect
use
proport
chanc
criterion
maximum
chanc
criterion
method
group
hitrat
estim
statist
evalu
use
proport
chanc
criterion
overal
group
hit
rate
deem
statist
better
chanc
expect
descript
measur
calcul
denot
percent
improv
chanc
expect
data
set
higher
percentag
patient
die
live
hlab
allel
inform
avail
patient
data
set
includ
patient
infect
ehf
outbreak
uganda
exact
probabl
surviv
ehf
exactli
known
prior
probabl
group
membership
set
valu
close
sampl
estim
p
p
current
data
set
pda
analys
perform
use
discrimin
procedur
ssp
softwar
version
spss
pda
analysesinterpret
done
accord
establish
guidelin
hlab
predictor
variabl
dichotom
variabl
discrimin
analysi
procedur
assum
multivari
normal
classif
analys
also
done
use
proc
logist
sa
softwar
version
sa
institut
well
variou
kernel
discrimin
analysi
option
use
proc
discrim
sa
softwar
version
ident
near
ident
result
obtain
use
statist
procedur
result
hlab
allel
assign
patient
type
present
tabl
show
patient
b
allel
surviv
sebov
diseas
fortun
allel
includ
mhc
bindingctl
predict
program
allow
analysi
predict
amino
acid
sequenc
among
gene
sudan
ebov
gulu
potenti
epitop
tabl
list
potenti
hlab
epitop
identifi
predict
softwar
top
rank
epitop
present
l
protein
present
nucleoprotein
lowerrank
epitop
locat
l
protein
protein
highestrank
epitop
highli
conserv
ebov
partial
conserv
marburg
viru
marv
relat
filoviru
nucleoprotein
epitop
secondrank
epitop
highli
conserv
ebov
marv
thirdrank
epitop
conserv
sequenc
fourthand
fifthrank
epitop
respect
show
conserv
highli
conserv
ebov
univari
associ
patient
surviv
chanc
alon
expect
patient
would
classifi
correct
outcom
group
basi
result
loo
method
overal
classif
accuraci
rate
patient
mark
improv
chanc
expect
p
use
proport
chanc
criterion
tabl
overal
classif
accuraci
statist
better
chanc
basi
z
p
p
maximum
chanc
criterion
ie
classif
subject
largest
group
patient
would
correctli
classifi
chanc
alon
basi
maximum
chanc
criterion
overal
hit
rate
better
chanc
use
z
p
p
p
proport
chanc
criterion
group
hit
rate
also
statist
better
chanc
z
p
p
group
patient
die
ehf
p
insert
valu
allel
denot
genet
absenc
valu
denot
genet
presenc
allel
allow
calcul
lcfdead
lcfaliv
valu
patient
assign
group
higher
lcf
valu
sebov
outbreak
uganda
determin
person
fatal
outcom
sebov
diseas
higher
viru
load
surviv
diseas
surviv
like
depend
rapid
develop
effect
ctl
respons
limit
level
viru
replic
overwhelm
bodi
evidenc
increas
number
activ
hladr
lymphocyt
patient
nonfat
case
studi
suggest
mhc
class
composit
appear
import
factor
diseas
outcom
presenc
certain
hlab
allel
confer
either
protect
advantag
disadvantag
patient
infect
sebov
find
indic
ex
pression
b
allel
highli
associ
surviv
confer
phenotyp
effici
drive
cell
activ
ctl
expans
earli
sebov
infect
wherea
allel
highli
associ
fatal
eg
b
b
contribut
ineffici
unrespons
phenotyp
one
sebovinfect
patient
surviv
b
profil
involv
good
bad
allel
suggest
b
allel
may
suffici
restrict
sebov
replic
data
one
might
abl
model
surviv
patient
one
good
allel
one
bad
allel
howev
present
studi
patient
profil
therefor
univari
associ
allel
type
patient
surviv
possibl
correl
hla
composit
diseas
suscept
sever
identifi
viral
infect
includ
due
hiv
herp
virus
hepat
b
c
virus
dengu
viru
hantavirus
sever
acut
respiratori
syndrom
coronaviru
also
report
hlabrestrict
epitop
exhibit
greater
function
avid
cell
receptor
avid
hlapeptid
complex
hlaaor
hlacrestrict
epitop
suggest
signific
role
hlab
allel
acquir
antivir
immun
believ
also
case
sebov
infect
although
shown
hlab
profil
patient
sebov
infect
associ
diseas
outcom
addit
investig
need
character
find
applic
mhc
class
tetram
technolog
could
use
analyz
pbmc
isol
person
surviv
sebov
diseas
futur
case
sebov
diseas
determin
whether
epitop
predict
tabl
immunodomin
hlab
respons
also
need
examin
hlab
profil
patient
infect
filovirus
would
extrem
help
gaug
influenc
hlab
locu
filoviru
clearanc
could
use
develop
refin
vaccin
abil
predict
capac
individu
control
acut
lifethreaten
infect
infect
caus
filovirus
could
use
outbreak
current
futur
capabl
rapid
hla
type
could
easili
allow
type
test
perform
field
alongsid
clinic
assay
classif
function
lcfdead
lcfaliv
gener
pda
model
could
use
gaug
risk
provid
medic
assist
patient
sebov
infect
becom
infect
highrisk
individu
might
assign
duti
involv
less
contact
infect
patient
infecti
materi
similarli
patient
sebov
infect
might
manag
appropri
fatal
outcom
like
futur
type
patient
sebov
infect
would
use
assess
reliabl
tool
valid
tool
could
help
refin
classif
function
expand
scope
conclus
present
studi
provid
knowledg
first
evid
genet
predisposit
fatal
nonfat
diseas
outcom
patient
ebov
infect
indic
trait
link
allel
mhc
hlab
locu
associ
emphas
import
develop
time
ctl
respons
ebov
infect
lead
effici
viru
clearanc
hope
data
set
expand
includ
predict
diseas
outcom
zebov
marv
would
import
resourc
futur
investig
human
immun
respons
filoviru
infect
